SEC Comment Letter for Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114) (ARMP) — Apr 7, 2020
Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114)
Date: April 7, 2020 · CIK: 0000921114 · Accession: 0000000000-20-002969
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237534
Letter
April 6, 2020 Todd Patrick Chief Executive Officer Armata Pharmaceuticals, Inc. 4503 Glencoe Avenue Marina del Rey, CA 90292 Re:Armata Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed April 1, 2020 File No. 333-237534 Dear Mr. Patrick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Courtney Lindsay at (202) 551-7237 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Faith Charles
Show Raw Text
April 6, 2020
Todd Patrick
Chief Executive Officer
Armata Pharmaceuticals, Inc.
4503 Glencoe Avenue
Marina del Rey, CA 90292
Re:Armata Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed April 1, 2020
File No. 333-237534
Dear Mr. Patrick:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Courtney Lindsay at (202) 551-7237 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Faith Charles